Tirzepatide (LY3298176) Acetate (2023788-19-2 free base) is a new molecule that can control blood glucose levels by combining dual agonism of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors.[3]
Molecular Weight:
4873.5
Purity:
97.30%
Formula:
C227H352N48O70
Target:
Glucagon Receptor
TP1111L
* VAT and and shipping costs not included. Errors and price changes excepted